Cargando…

Risk Assessment of Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis Patients during 1 Year of Ocrelizumab Treatment

Background: Progressive multifocal leukoencephalopathy (PML) caused by the JC virus is the main limitation to the use of disease modifying therapies for treatment of multiple sclerosis (MS). Methods: To assess the PML risk in course of ocrelizumab, urine and blood samples were collected from 42 MS p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prezioso, Carla, Grimaldi, Alfonso, Landi, Doriana, Nicoletti, Carolina Gabri, Brazzini, Gabriele, Piacentini, Francesca, Passerini, Sara, Limongi, Dolores, Ciotti, Marco, Palamara, Anna Teresa, Marfia, Girolama Alessandra, Pietropaolo, Valeria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473394/ https://www.ncbi.nlm.nih.gov/pubmed/34578264 http://dx.doi.org/10.3390/v13091684

Ejemplares similares

Diagnostic Value of JC Polyomavirus Viruria, Viremia, Serostatus and microRNA Expression in Multiple Sclerosis Patients Undergoing Immunosuppressive Treatment
por: Prezioso, Carla, et al.
Publicado: (2022)

Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With Ocrelizumab
por: Landi, Doriana, et al.
Publicado: (2022)

Assessment of Macular Function by Multifocal Electroretinogram in Patients with Multiple Sclerosis Treated with Fingolimod
por: Barbano, Lucilla, et al.
Publicado: (2021)

COS-7 and SVGp12 Cellular Models to Study JCPyV Replication and MicroRNA Expression after Infection with Archetypal and Rearranged-NCCR Viral Strains
por: Prezioso, Carla, et al.
Publicado: (2022)

Multifocal Electroretinogram Photopic Negative Response: A Reliable Paradigm to Detect Localized Retinal Ganglion Cells’ Impairment in Retrobulbar Optic Neuritis Due to Multiple Sclerosis as a Model of Retinal Neurodegeneration
por: Barbano, Lucilla, et al.
Publicado: (2022)

Mild progressive multifocal leukoencephalopathy after switching from natalizumab to ocrelizumab
por: Toorop, Alyssa A., et al.
Publicado: (2020)

New Insights on Human Polyomavirus JC and Pathogenesis of Progressive Multifocal Leukoencephalopathy
por: Bellizzi, Anna, et al.
Publicado: (2013)

Mild clinical manifestations of SARS-CoV-2 related pneumonia in two patients with multiple sclerosis under treatment with ocrelizumab
por: Iannetta, Marco, et al.
Publicado: (2020)

Prevalence of MCPyV, HPyV6, HPyV7 and TSPyV in Actinic Keratosis Biopsy Specimens
por: Prezioso, Carla, et al.
Publicado: (2022)

Patient’s point of view on the use of telemedicine in multiple sclerosis: a web-based survey
por: Landi, Doriana, et al.
Publicado: (2021)

COVID-19 vaccine hesitancy among Italian people with multiple sclerosis
por: Proietti, Francesca, et al.
Publicado: (2022)

Adherence to social distancing and use of personal protective equipment and the risk of SARS-CoV-2 infection in a cohort of patients with multiple sclerosis
por: Landi, Doriana, et al.
Publicado: (2020)

Functional Assessment of Outer and Middle Macular Layers in Multiple Sclerosis
por: Ziccardi, Lucia, et al.
Publicado: (2020)

T-cell responses to SARS-CoV-2 in multiple sclerosis patients treated with ocrelizumab healed from COVID-19 with absent or low anti-spike antibody titers
por: Iannetta, Marco, et al.
Publicado: (2021)

Topographical Correlation between Structural and Functional Impairment of the Macular Inner Retinal Layers in Multiple Sclerosis Eyes with a History of Optic Neuropathy
por: Parisi, Vincenzo, et al.
Publicado: (2023)

CD19 Cell Count at Baseline Predicts B Cell Repopulation at 6 and 12 Months in Multiple Sclerosis Patients Treated with Ocrelizumab
por: Abbadessa, Gianmarco, et al.
Publicado: (2021)

Progressive Multifocal Leukoencephalopathy
por: Adang, Laura, et al.
Publicado: (2015)

Treatment of progressive multifocal leukoencephalopathy
por: Castle, Daniel, et al.
Publicado: (2019)

Safety of Natalizumab infusion in multiple sclerosis patients during active SARS-CoV-2 infection
por: Landi, Doriana, et al.
Publicado: (2022)

Progressive Multifocal Leukoencephalopathy in an Immunocompetent Patient?
por: Johansen, Krisztina K., et al.
Publicado: (2013)

Progressive multifocal leukoencephalopathy in an immunocompetent patient
por: van der Kolk, Nicolien M., et al.
Publicado: (2016)

Diagnostic delay in progressive multifocal leukoencephalopathy
por: Miskin, Dhanashri P., et al.
Publicado: (2016)

Progressive multifocal leukoencephalopathy in the absence of immunosuppression
por: Zucker, Benjamin E., et al.
Publicado: (2017)

Progressive Multifocal Leukoencephalopathy: Current Insights
por: Kartau, Marge, et al.
Publicado: (2019)

AIDS-related progressive multifocal leukoencephalopathy
por: Abrão, Carolina de Oliveira, et al.
Publicado: (2020)

Atezolizumab Treatment for Progressive Multifocal Leukoencephalopathy
por: Lambert, Nicolas, et al.
Publicado: (2022)

Advances in Treatment of Progressive Multifocal Leukoencephalopathy
por: Bernard‐Valnet, Raphaël, et al.
Publicado: (2021)

Detection of Merkel Cell Polyomavirus (MCPyV) DNA and Transcripts in Merkel Cell Carcinoma (MCC)
por: Passerini, Sara, et al.
Publicado: (2023)

Rituximab-Associated Inflammatory Progressive Multifocal Leukoencephalopathy
por: Punch, Chandra, et al.
Publicado: (2016)

Progressive multifocal leukoencephalopathy in non-HIV patient
por: Vieira, Diego Rosseman, et al.
Publicado: (2016)

Progressive Multifocal Leukoencephalopathy after Treatment with Nivolumab
por: Martinot, Martin, et al.
Publicado: (2018)

Progressive multifocal leukoencephalopathy after fingolimod treatment
por: Berger, Joseph R., et al.
Publicado: (2018)

Natalizumab: Progressive multifocal leukoencephalopathy: case report
Publicado: (2021)

Innovative therapeutic concepts of progressive multifocal leukoencephalopathy
por: Möhn, Nora, et al.
Publicado: (2022)

Progressive multifocal leukoencephalopathy without overt immunosuppression
por: Jain, Varun, et al.
Publicado: (2023)

Milky Way Sign in Progressive Multifocal Leukoencephalopathy
por: Agarwal, Ayush, et al.
Publicado: (2022)

Optimizing the “Time to pregnancy” in women with multiple sclerosis: the OPTIMUS Delphi survey
por: Carbone, Luigi, et al.
Publicado: (2023)

Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression
por: Albanese, Maria, et al.
Publicado: (2016)

Structural Analysis of Merkel Cell Polyomavirus (MCPyV) Viral Capsid Protein 1 (VP1) in HIV-1 Infected Individuals
por: Prezioso, Carla, et al.
Publicado: (2020)

Evolution of progressive multifocal leukoencephalopathy in HIV-infected patients
por: Iancu, Ana Maria, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_bojt7h57m3ifbijrec06l3mo5a